APA (7th ed.) Citation

Ghetti G, Pradelli L, Papageorgiou G, Karpouzos G, & Arikan Y. (2023). CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece. Dove Medical Press.

Chicago Style (17th ed.) Citation

Ghetti G, Pradelli L, Papageorgiou G, Karpouzos G, and Arikan Y. CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Ghetti G, et al. CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece. Dove Medical Press, 2023.